Q-omics provides the consensus-scored RNU6ATAC23P profile across patient tissues and cancer cell-line models. RNU6ATAC23P expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RNU6ATAC23P RNA expression shows 7,252 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight KIRC, and BRCA as cancer lineages where RNU6ATAC23P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.